Patents Assigned to Bridge Bioresearch Limited
  • Use of soluble CD14 for treatment of type 2 diabetes mellitus
    Patent number: 7655237
    Abstract: Use of soluble CD14 (sCD14) for the manufacture of a medicament for therapeutic or preventive treatment of a disease involving a chronic inflammation condition and a clinical disorder associated with insulin resistance in an animal or a human. Examples of diseases include type 2 diabetes mellitus, obesity, metabolic syndrome, arteriosclerotic disease, arterial hypertension and functional ovaric hyperandrogenism.
    Type: Grant
    Filed: February 23, 2004
    Date of Patent: February 2, 2010
    Assignee: Bridge Bioresearch Limited
    Inventors: José Fernandez-Real, Wifredo Engel
  • Use of BPI Protein for Treatment of Diseases
    Publication number: 20090215684
    Abstract: Use of a bactericidal/permeability-increasing (BPI) protein product for the manufacture of a medicament for therapeutic or preventive treatment of a disease involving a clinical disorder associated with insulin resistance in a human.
    Type: Application
    Filed: July 7, 2006
    Publication date: August 27, 2009
    Applicant: BRIDGE BIORESEARCH LIMITED
    Inventors: Jose Manuel Fernandez-Real Lemos, Wifredo Ricart Engel